SCHEMBL5406

SCHEMBL5406

CCC[C@]1(O)CC[C@]2(CCN(c3ccc(S(=O)(=O)CC)cc3)C2)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNJ1 P48048 2/20 0.39
CYP2C19 P33261 9/20 0.38
CYP3A4 P08684 9/20 0.38
CYP2C9 P11712 8/20 0.38
CYP1A2 P05177 7/20 0.38
ALDH1A1 P00352 5/20 0.38
USP2 O75604 5/20 0.38
TSHR P16473 3/20 0.38
CYP2D6 P10635 3/20 0.38
HIF1A Q16665 5/20 0.37
SMN1; SMN2 Q16637 5/20 0.37
MAPK1 P28482 1/20 0.37
LIPE Q05469 1/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
HSD17B10 Q99714 2/20 0.36
HPGD P15428 1/20 0.36
ALOX15 P16050 1/20 0.36
ITGB3 P05106 2/20 0.35
ITGA2B P08514 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5651 0.80 LIPE (0.38) CYP2C19CYP3A4CYP2C9CYP1A2ALDH1A1
SCHEMBL5924 0.79 ITGB3 (0.38) CYP2C19CYP3A4CYP2C9CYP1A2ALDH1A1
SCHEMBL5639 0.76 S1PR1 (0.41) CYP2C19CYP3A4CYP2C9CYP1A2ALDH1A1
SCHEMBL5614 0.76 LIPE (0.60) LIPE
SCHEMBL4962 0.75 RYR2 (0.41) CYP2C19CYP3A4CYP2C9CYP1A2ALDH1A1
SCHEMBL10259 0.75 LIPE (0.64) KCNJ1LIPEITGB3ITGA2B
SCHEMBL10258 0.75 LIPE (0.64) KCNJ1LIPEITGB3ITGA2B
SCHEMBL12072 0.73 KCNJ1 (0.36) KCNJ1LIPEITGB3ITGA2B
SCHEMBL12419729 0.70 KDM4E (0.48) ALDH1A1SMN1; SMN2MEN1KMT2AHPGD
SCHEMBL5485 0.69 RYR2 (0.45) CYP2C19CYP3A4CYP2C9CYP1A2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488493-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. Hoffmann-La Roche AG (CH) 2012-08-22 EP claimed
WO-2011045292-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-04-21 WO claimed